DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sept 2019 4:34 PM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...